Crohn's disease Stories
- Johnson & Johnson's Stelara was significantly better than placebo at inducing clinical response and remissions in patients with moderate to severe Crohn's disease, according to data from a late stage trial, providing ammunition for a potential expanded approval of the medicine.
- Probiotics might reduce behavioral problems associated with chronic inflammatory diseases, suggesting a link between the brain and immune system.
- Immune-modulating drug thalidomide induced clinical remission for pediatric Crohn's disease sufferers for more than 180 weeks.
- Shreddies underwear uses chemical warfare technology to trap odor particles that are up to 200 times stronger than the average fart.
- Two studies show promising results for vedolizumab as a drug candidate for Crohn’s disease and ulcerative colitis.
Crohn's Disease Linked To Presence Of Enterovirus In Children; Testing And Vaccination Could Be An OptionAdding a second piece to the puzzle of Crohn's disease, scientists have linked the condition to enterovirus in children.
- NIH researchers linked altered BACH2 genes to cases of Crohn's disease, type 1 diabetes, celiac disease, and asthma, among other autoimmune disorders.
- A new study suggests it may be possible to test for potential side effects of the Crohn's disease drug infliximab before treatment is administered.
- Treatment through cannabis may be beneficial to patients with Crohn's disease, new research finds.
- The genes that lead to autoimmune inflammatory diseases like MS, Crohn’s disease, and rheumatoid arthritis may have actually benefited our early ancestors– more evidence for the hygiene hypothesis.
- Massachusetts-based company Coronado Biosciences is developing a new class of treatments to fight autoimmune disorders.